Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc. - ROEverified

AMPH

Price:

$18.81

Market Cap:

$829.39M

Amphastar Pharmaceuticals, Inc., established in 1996 and based in Rancho Cucamonga, California, functions as a biopharmaceutical enterprise. The company is engaged in the creation, production, commercialization, and distribution of both generic and proprietary pharmaceutical products, which include injectables, inhalants, and intranasal formulations. Its market presence extends across the United States, China, and France. Amphastar's operations are divided into two primary segments: Finished Pharmaceutical Products and Active Pharmaceutical Ingredients (API). The company's extensive product portfolio encompasses a variety of crucial medications. These feature Primatene Mist, an over-the-coun...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2014-06-25

Stock Exchange

NASDAQ

Ticker

AMPH

The ROE as of June 2026 (TTM) for Amphastar Pharmaceuticals, Inc. (AMPH) is 10.23%

According to Amphastar Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 10.23%. This represents a change of 299.13% compared to the average of 2.56% of the last 4 quarters.

Amphastar Pharmaceuticals, Inc. (AMPH) Historical ROE (quarterly & annually)

How has AMPH ROE performed in the past?

The mean historical ROE of Amphastar Pharmaceuticals, Inc. over the last ten years is 10.29%. The current 10.23% ROE has changed -0.58% with respect to the historical average. Over the past ten years (40 quarters), AMPH's ROE was at its highest in in the June 2019 quarter at 12.32%. The ROE was at its lowest in in the March 2018 quarter at -2.22%.

Quarterly (TTM)
Annual

Average

10.29%

Median

12.63%

Minimum

-1.73%

Maximum

21.78%

Amphastar Pharmaceuticals, Inc. (AMPH) ROE by Quarter and Year

Discovering the peaks and valleys of Amphastar Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 3.90%

Maximum Annual ROE = 21.78%

Minimum Annual Increase = -843.46%

Minimum Annual ROE = -1.73%

Quarterly (TTM)
Annual
YearROEChange
202512.44%-42.91%
202421.78%1.27%
202321.51%24.44%
202217.29%23.99%
202113.94%3.90%
20200.35%-97.28%
201912.83%-843.46%
2018-1.73%-229.16%
20171.34%-58.22%
20163.20%-439.17%

Amphastar Pharmaceuticals, Inc. (AMPH) Average ROE

How has AMPH ROE performed in the past?

The current ROE of Amphastar Pharmaceuticals, Inc. (AMPH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

18.58%

5-year avg

17.39%

10-year avg

10.29%

Amphastar Pharmaceuticals, Inc. (AMPH) ROE vs. Peers

How is AMPH’s ROE compared to its peers?

Amphastar Pharmaceuticals, Inc.’s ROE is greater than Dynavax Technologies Corporation (-8.05%), less than Collegium Pharmaceutical, Inc. (26.74%), less than Pacira BioSciences, Inc. (0.73%), less than CureVac N.V. (18.40%), greater than Embecta Corp. (-17.49%), greater than Harrow Health, Inc. (-33.65%), greater than Syndax Pharmaceuticals, Inc. (-256.66%), greater than Inhibrx Biosciences, Inc. (-563.89%), greater than AdaptHealth Corp. (-5.11%), greater than Beta Bionics, Inc. (-23.00%),

Build a custom stock screener for Amphastar Pharmaceuticals, Inc. (AMPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amphastar Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Amphastar Pharmaceuticals, Inc. (AMPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Amphastar Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Amphastar Pharmaceuticals, Inc.'s ROE?

How is the ROE calculated for Amphastar Pharmaceuticals, Inc. (AMPH)?

What is the highest ROE for Amphastar Pharmaceuticals, Inc. (AMPH)?

What is the 3-year average ROE for Amphastar Pharmaceuticals, Inc. (AMPH)?

What is the 5-year average ROE for Amphastar Pharmaceuticals, Inc. (AMPH)?

How does the current ROE for Amphastar Pharmaceuticals, Inc. (AMPH) compare to its historical average?